Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
American Journal of Respiratory and Critical Care Medicine
|
January 14, 2021
Reply to López-Campos <i>et al.</i> and to Rogliani and Calzetta
Fernando J Martinez, Patrick Darken, Paul Dorinsky
The Lancet. Respiratory Medicine
|
August 22, 2021
Perplexing mortality data from triple therapy trials in COPD - Author's reply
Fernando J Martinez, Patrick Darken, Paul Dorinsky, et al.
Respiratory Research
|
June 29, 2021
Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
Shigeo Muro, Hisatoshi Sugiura, Patrick Darken, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
October 19, 2007
Ciclesonide and beclomethasone dipropionate coadministration: effect on cortisol in perennial allergic rhinitis
Paul Ratner, Patrick Darken, Mark Wingertzahn, et al.
Pharmaceutical Statistics
|
March 22, 2020
The attributable estimand: A new approach to account for intercurrent events
Patrick Darken, Jack Nyberg, Shaila Ballal, et al.
Respiratory Research
|
August 10, 2021
Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
Shigeo Muro, Hisatoshi Sugiura, Patrick Darken, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
September 22, 2007
Intranasal ciclesonide coadministration with inhaled fluticasone propionate-salmeterol does not suppress cortisol in allergic rhinitis patients
Kenneth Kim, Javier Quesada, Nancy Szmaydy-Rikken, et al.
Clinical Trials (London, England)
|
December 21, 2023
Algorithmic benchmark modulation: A novel method to develop success rates for clinical studies
Bart Ja Willigers, Sridevi Nagarajan, Serban Ghiorghui, et al.
Pulmonary Pharmacology & Therapeutics
|
March 17, 2018
The pharmacokinetics of three doses of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler compared with active controls: A Phase I randomized, single-dose, crossover study in healthy adults
Patrick Darken, Paolo DePetrillo, Colin Reisner, et al.
Chest
|
June 11, 2003
Cardiovascular safety of salmeterol in COPD
Gary T Ferguson, Christian Funck-Brentano, Tracy Fischer, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
American Journal of Respiratory and Critical Care Medicine
|
January 14, 2021
Reply to López-Campos <i>et al.</i> and to Rogliani and Calzetta
Fernando J Martinez, Patrick Darken, Paul Dorinsky
The Lancet. Respiratory Medicine
|
August 22, 2021
Perplexing mortality data from triple therapy trials in COPD - Author's reply
Fernando J Martinez, Patrick Darken, Paul Dorinsky, et al.
Respiratory Research
|
June 29, 2021
Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
Shigeo Muro, Hisatoshi Sugiura, Patrick Darken, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
October 19, 2007
Ciclesonide and beclomethasone dipropionate coadministration: effect on cortisol in perennial allergic rhinitis
Paul Ratner, Patrick Darken, Mark Wingertzahn, et al.
Pharmaceutical Statistics
|
March 22, 2020
The attributable estimand: A new approach to account for intercurrent events
Patrick Darken, Jack Nyberg, Shaila Ballal, et al.
Respiratory Research
|
August 10, 2021
Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
Shigeo Muro, Hisatoshi Sugiura, Patrick Darken, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
September 22, 2007
Intranasal ciclesonide coadministration with inhaled fluticasone propionate-salmeterol does not suppress cortisol in allergic rhinitis patients
Kenneth Kim, Javier Quesada, Nancy Szmaydy-Rikken, et al.
Clinical Trials (London, England)
|
December 21, 2023
Algorithmic benchmark modulation: A novel method to develop success rates for clinical studies
Bart Ja Willigers, Sridevi Nagarajan, Serban Ghiorghui, et al.
Pulmonary Pharmacology & Therapeutics
|
March 17, 2018
The pharmacokinetics of three doses of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler compared with active controls: A Phase I randomized, single-dose, crossover study in healthy adults
Patrick Darken, Paolo DePetrillo, Colin Reisner, et al.
Chest
|
June 11, 2003
Cardiovascular safety of salmeterol in COPD
Gary T Ferguson, Christian Funck-Brentano, Tracy Fischer, et al.
Page
of 5